| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.852 | 5.928 | 6.604 | 3.026 | 0 | 0 | 162 | 0 | 0 | 0 |
| Total Income - EUR | 11.852 | 5.928 | 6.604 | 3.026 | 0 | 0 | 162 | 0 | 0 | 0 |
| Total Expenses - EUR | 12.941 | 11.168 | 9.826 | 2.587 | 832 | 1.228 | 853 | 603 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.089 | -5.240 | -3.222 | 439 | -832 | -1.228 | -692 | -603 | 0 | 0 |
| Net Profit/Loss - EUR | -1.444 | -5.418 | -3.420 | 348 | -832 | -1.228 | -693 | -603 | 0 | 0 |
| Employees | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio-Asisvet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.070 | 6.808 | 6.506 | 6.202 | 6.052 | 5.938 | 5.806 | 5.824 | 5.806 | 5.774 |
| Current Assets | 10.559 | 12.691 | 12.356 | 10.143 | 9.755 | 9.554 | 9.312 | 9.464 | 9.436 | 9.383 |
| Inventories | 585 | 579 | 569 | 559 | 548 | 538 | 526 | 527 | 526 | 523 |
| Receivables | 8.151 | 9.627 | 9.983 | 9.800 | 9.610 | 9.428 | 9.219 | 9.247 | 9.219 | 9.168 |
| Cash | 1.824 | 2.485 | 1.804 | -215 | -403 | -411 | -433 | -310 | -309 | -308 |
| Shareholders Funds | 11.011 | 5.481 | -315 | 39 | -794 | -2.007 | -2.656 | -3.267 | -3.257 | -3.239 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.619 | 14.018 | 19.176 | 16.306 | 16.601 | 17.499 | 17.774 | 18.555 | 18.499 | 18.396 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Bio-Asisvet S.r.l.